Quarterly ResultMay 5, 2026, 04:03 PM
AtriCure Q1 Revenue $141.2M, Net Income $0.1M; Adjusted EBITDA +95%
AI Summary
AtriCure, Inc. reported strong first quarter 2026 financial results, with worldwide revenue increasing 14.3% to $141.2 million and U.S. revenue growing 14.9% to $116.2 million. The company achieved net income of $0.1 million, a significant improvement from a net loss of $6.7 million in the prior year, and adjusted EBITDA surged 95% to $17.1 million. AtriCure also provided positive full-year 2026 guidance, projecting revenue between $600 million and $610 million and adjusted EBITDA of $80 million to $82 million.
Key Highlights
- Q1 2026 worldwide revenue was $141.2 million, an increase of 14.3% year-over-year.
- Q1 2026 U.S. revenue increased 14.9% to $116.2 million, driven by AtriClip FLEX-Mini , cryoSPHERE MAX , EnCompass clamp, and AtriClip PRO-Mini .
- Q1 2026 net income was $0.1 million, compared to a net loss of $6.7 million in Q1 2025.
- Q1 2026 adjusted EBITDA rose 95% to $17.1 million.
- Q1 2026 gross margin improved to 77.4%, an increase of 246 basis points.
- Full year 2026 revenue is projected to be $600 million to $610 million.
- Full year 2026 adjusted EBITDA is projected to be $80 million to $82 million.